Smith & Nephew (SNN) Share-based Compensation Growth (3y) (2012 - 2024)
Smith & Nephew (SNN) Share-based Compensation Growth (3y) (2012 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 5.29% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 13.40% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 0.56% |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | - |
| 10 | Steris | 21.34 Bn | 20.90 Bn | 697.10 Mn | 12.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.55% |
| Dec 31, 2023 | 8.20% |
| Dec 31, 2022 | 10.60% |
| Dec 31, 2021 | 8.51% |
| Dec 31, 2020 | 0.00% |
| Dec 31, 2019 | 6.69% |
| Dec 31, 2018 | 11.46% |
| Dec 31, 2017 | -2.13% |
| Dec 31, 2016 | 15.87% |
| Dec 31, 2015 | 13.04% |
| Dec 31, 2014 | 31.73% |
| Sep 30, 2014 | 0.00% |
| Mar 31, 2014 | 8.74% |
| Dec 31, 2013 | 21.64% |
| Mar 31, 2013 | 7.72% |
| Dec 31, 2012 | 31.04% |
| Jun 30, 2012 | 28.92% |
| Mar 31, 2012 | 18.56% |